Evidence map›Paper›PMID 42274558›Full record

ArticleCells2026

Proteomic Analysis of the Metabolic Response of UVA-Exposed Melanocytes Following Co-Treatment with Cannabigerol and 3-

Magda Mucha, Alena Ryšavá, Iwona Jarocka-Karpowicz, Audrius Maruška, Elżbieta Skrzydlewska, Agnieszka Gęgotek

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Magda MuchaDepartment of Analytical Chemistry, Medical University of Bialystok, Kilinskiego 1, 15-069 Bialystok, Poland.
Alena RyšaváDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 779 00 Olomouc, Czech Republic.ORCID 0000-0001-8218-3987
Iwona Jarocka-KarpowiczDepartment of Analytical Chemistry, Medical University of Bialystok, Kilinskiego 1, 15-069 Bialystok, Poland.ORCID 0000-0001-8923-3529
Audrius MaruškaInstrumental Analysis Open Access Center, Faculty of Natural Sciences, Vytautas Magnus University, Vileikos 8, LT-44404 Kaunas, Lithuania.ORCID 0000-0002-9267-3805
Elżbieta SkrzydlewskaDepartment of Analytical Chemistry, Medical University of Bialystok, Kilinskiego 1, 15-069 Bialystok, Poland.ORCID 0000-0001-5397-7139
Agnieszka GęgotekDepartment of Analytical Chemistry, Medical University of Bialystok, Kilinskiego 1, 15-069 Bialystok, Poland.ORCID 0000-0002-5240-1346

Funding

Narodowa Agencja Wymiany Akademickiej BPI/PST/2024/1/00008
6 · The paper itself

Abstract

The aim of this study was to analyze the effect of concomitant use of cannabigerol (CBG) and 3-

Indexed as

Ascorbic AcidCannabinoidsMelanocytesProteomeProteomicsUltraviolet RaysAldehydesHumansLipid PeroxidationAldehydesAscorbic AcidcannabigerolCannabinoidsProteome3-O-ethyl ascorbic acidcannabigerolmelanocytesproteomicsskin protectionUVA radiation

Identifiers

PMID42274558
PMCPMC13256526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.